Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Small Cell Lung Carcinoma × Afatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 18 Lung Neoplasms 6 Breast Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Head and Neck Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Neoplasms 4 Neoplasm Metastasis 4 Carcinoma, Squamous Cell 4 Stomach Neoplasms 2 Prostatic Neoplasms 2 Non-small-cell Lung Cancer With Somatic EGFR Mutations 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Adenocarcinoma of Lung 2 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Cancers of the Head and Neck 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Pathologic Complete Response 1 PFS 1 NSCLC Harboring NRG1 Fusion 1 Multiple Myeloma 1 Lymphoma 1 Gallbladder Neoplasms 1 Focus of Study Instead 1

Interventions

Etoposide 70 Carboplatin 60 Cisplatin 40 Topotecan 26 durvalumab 25 atezolizumab 18 Radiotherapy 18 Irinotecan 18 Paclitaxel 15 Nivolumab 15 apatinib 14 anlotinib 12 Drug Therapy 12 pembrolizumab 9 Platinum 9 toripalimab 8 Bevacizumab 8 Radiosurgery 7 PM 01183 7 Ipilimumab 7 tislelizumab 6 Gemcitabine 6 olaparib 5 amrubicin 5 Temozolomide 5 Sunitinib 5 Pemetrexed 5 Docetaxel 5 Albumin-Bound Paclitaxel 5 irinotecan sucrosofate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02876081 2017-09-11

THEN

Fondation Hôpital Saint-Joseph

Phase 2 Withdrawn

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡